OCIPERLIMAB: 48 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
48
Total FAERS Reports
5 (10.4%)
Deaths Reported
44
Hospitalizations
48
As Primary/Secondary Suspect
7
Life-Threatening
First Report: 20210512 · Latest Report: 20230807
What Are the Most Common OCIPERLIMAB Side Effects?
#1 Most Reported
Pneumonia
6 reports (12.5%)
#2 Most Reported
White blood cell count decreased
5 reports (10.4%)
#3 Most Reported
Febrile neutropenia
4 reports (8.3%)
All OCIPERLIMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Pneumonia | 6 | 12.5% | 0 | 6 |
| White blood cell count decreased | 5 | 10.4% | 0 | 5 |
Who Reports OCIPERLIMAB Side Effects? Age & Gender Data
Gender: 5.2% female, 94.8% male. Average age: 67.5 years. Most reports from: CN. View detailed demographics →
Is OCIPERLIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 2 | 0 | 2 |
| 2022 | 23 | 4 | 22 |
| 2023 | 21 | 1 | 20 |
What Is OCIPERLIMAB Used For?
| Indication | Reports |
|---|---|
| Non-small cell lung cancer metastatic | 34 |
| Non-small cell lung cancer | 6 |
Official FDA Label for OCIPERLIMAB
Official prescribing information from the FDA-approved drug label.